- Home
- EQS vs HKPD Comparison
EQS vs HKPD Comparison
Compare EQS & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQS | HKPD |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Finance Companies | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 10.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | EQS | HKPD |
|---|---|---|
| Price | $1.74 | $0.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.0K | ★ 129.4K |
| Earning Date | 01-01-0001 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,377,000.00 | ★ $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 21.11 | ★ 21.72 |
| 52 Week Low | $0.74 | $0.72 |
| 52 Week High | $2.49 | $3.79 |
Technical Indicators
Market Signals| Indicator | EQS | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 27.59 |
| Support Level | $1.64 | $0.76 |
| Resistance Level | $1.90 | $0.86 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 14.29 | 6.80 |
Price Performance
Historical ComparisonAbout EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.